Skip to main content
Frederick Lang Jr., MD, Neurosurgery, Houston, TX

FrederickF.LangJr.MD

Neurosurgery Houston, TX

Brain & Spinal Tumor

Chair & Professor of Neurosurgery at The University of Texas MD Anderson Cancer Center

Dr. Lang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lang's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd,
    Unit 442
    Houston, TX 77030
    Phone+1 713-792-2736

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Neurosurgical Oncology, 1995 - 1996
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Neurological Surgery, 1989 - 1995
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineInternship, Surgery, 1988 - 1989
  • Yale School of Medicine
    Yale School of MedicineClass of 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2024 - 2026
  • TN State Medical License
    TN State Medical License 2024 - 2026
  • TX State Medical License
    TX State Medical License 1996 - 2026
  • GA State Medical License
    GA State Medical License 2024 - 2025
  • LA State Medical License
    LA State Medical License 2024 - 2025
  • MS State Medical License
    MS State Medical License 2024 - 2025
  • American Board of Neurological Surgery Neurological Surgery
  • Join now to see all

Awards, Honors, & Recognition

  • Listed on Texas Super Doctors List Super Doctors, 2020-2021
  • 2020 Annual Andrew Connor Curtis Endowed Featured Speaker Leonard M. Miller School of Medicine, University of Miami, 2020
  • Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research The University of Texas MD Anderson Cancer Center, 2019
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Predicting glioblastoma recurrence with hyperpolarized magnetic resonance
    Salzillo T, Gumin J, Lee J, Millward NZ, Gammon ST, Lang FF, Bhattacharya P, World Molecular Imaging Congress 2021 Meeting, Miami, FL, 10/2021
  • 4th Ventricle Subependymoma: To operate or not to operate?
    Haider AS, Ene C, Fuller GN, Schomer DF, Gule-Monroe MK, DeMonte F, Ferguson SD, Lang FF, McCutcheon I, Prabhu S, Raza SM, Suki D, Weinberg JS, Sawaya R, Congress of Neurological Surgeons Annual Meeting, Austin, TX, 10/2021
  • Predictors of overall survival (OS) in patients (Pts) with melanoma brain metastasis (MBM) in the modern era
    Hasanov M, Milton DR, Davies A, Sirmans E, Saberian C, Posada E, Gershenwald JE, Torres-Cabala CA, Huse JT, Tawbi HA, Glitza IC, Li J, Chung C, Yeboa DN, Opusunju S, K..., American Society of Clinical Oncology, Virtual, 6/2021
  • Join now to see all

Lectures

  • Biological Therapies for Brain Tumors: Oncolytic Viruses & Bone Marrow Stem Cells' 
    NYU Langone Health Neurosurgery Grand Rounds, New York, NY - 10/2021
  • Neurosurgical Management of Low Grade Gliomas: Insular Tumors 
    26th Annual Meeting of the Japanese Congress for Brain Tumor Surgery, Virtual - 9/2021
  • Biological Therapies for Gliomas: Viruses and Stem Cells 
    The University of Texas at Austin Dell Medical School Dept. of Neurosurgery Grand Rounds - 8/2021
  • Join now to see all

Press Mentions

  • Intratumoral Viral Delivery Improves Glioblastoma Survival
    Intratumoral Viral Delivery Improves Glioblastoma SurvivalMay 17th, 2023
  • Combined Delivery of Engineered Virus with Immunotherapy Is Safe and Improves Outcomes in Subset of Patients with Glioblastoma
    Combined Delivery of Engineered Virus with Immunotherapy Is Safe and Improves Outcomes in Subset of Patients with GlioblastomaMay 15th, 2023
  • Physician-Scientist Focused on Improving Brain Metastases Treatment
    Physician-Scientist Focused on Improving Brain Metastases TreatmentFebruary 17th, 2023
  • Join now to see all

Grant Support

  • Systematic Dissection of Function and Mechanism of Long Non-Coding RNAs in GlioblastomaNIH/NCI2021–2026
  • Glioma Therapy with Oncolytic Adenoviruses and Immunometabolic AdjuvantsNIH/NCI2021–2026
  • New Therapeutic Approaches for Stratified High-REST GBM SubtypeNIH/NINDS2020–2025
  • Determining the Optimal Ion and Fractionation Scheme for the Treatment of GBM in a Comprehensive Human Organoid ModelNIH/NCI2020–2025
  • A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for GlioblastomaNIH/NCI2020–2025
  • Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5NIH/NCI2019–2024
  • SPORE Director, Project 1 Co-Leader, CEP, DRP, Administrative Core, Pathology and Biorepository Core DirectorsNIH/NCI2013–2024
  • Cancer Center Support Grant (CCSG) Brain Cancer ProgramNIH/NCI2013–2024
  • Counteracting Space Radiation by Targeting Neurogenesis in a Human Brain Organoid ModelNational Aeronautics and Space Administration (Subcontract with Baylor College of Medicine)2020–2023
  • MSC-Derived Exosomes and microRNA in Glioma TherapyNIH/NCI2017–2022
  • Glioblastoma Moonshot: Longitudinal CSF and Blood Monitoring of Genomic Alterations in Patients & Phase I Clinical Trial of Delta-24-RGD Using BM-hMSCsThe University of Texas MD Anderson Cancer Center2014–2022
  • CE: Animal CoreNational Cancer Institute2008–2011
  • Bone Marrow Stem Cells: Novel Treatment Of Human GliomaNational Cancer Institute2006–2010
  • Regulation Of P53-Mediated Apoptosis In GliomasNational Cancer Institute2003–2007
  • Radiosensitization By Antiras Scfv-Expressing AdenovirusNational Cancer Institute2000

Professional Memberships